Cell Robotics' CEO Interviewed on CEOcast.

Business Editors & Health/Medical Writers

ALBUQUERQUE, N.M.--(BW HealthWire)--Oct. 18, 2000

Cell Robotics International Inc. (OTC:CRII), a manufacturer and marketer of medical and scientific laser devices, today announced that Dr. Ronald K. Lohrding, the Company's Chairman, President and CEO was interviewed on CEOcast (www.ceocast.com) on Oct. 17, 2000.

Additionally, Dr. Lohrding was interviewed on WallStreetReporter.com (www.wallstreetreporter.com) on Oct. 10, 2000.

Cell Robotics manufactures the award-winning Lasette(R), a miniature laser finger perforator, slightly larger than a cell phone, that allows diabetics to test blood glucose levels with minimal pain, no lingering soreness, less residual bleeding and eliminates the steel lancet for needle phobics.

"I was pleased to have been approached by both of these investor Web sites for an interview, mainly because I believe that it is important for the market to understand the various factors that we believe will positively impact the future of the Company," said Dr. Lohrding.

Dr. Lohrding cites the following factors as those that should positively impact Cell Robotics:

1. The passage of House Bill 5178, known as the Needlestick Safety and Prevention Act, by the House of Representatives. The bill, which passed by a unanimous vote, requires changes in bloodborne pathogens standards in effect under the Occupational Safety and Health Act of 1970 (OSHA) to mandate health facilities to employ measures to reduce or eliminate accidental needlesticks suffered by health care workers.

2. The ability to sell the current small Lasette(R) for both the home and in clinical applications at a time when the demand should increase dramatically for the clinical application because the Lasette completely eliminates the need for steel lancets in the clinical market.

3. The completion of the hiring of the regional sales staff, which will allow the Company to demonstrate the Lasette to more clinical institutions.

4. The start of advertising in clinical journals in addition to individual diabetic patient publication.

In addition to the Needlestick Safety and Prevention Act passed by the U.S. House of Representatives, eleven states have already passed similar legislation and twenty additional states also have legislation on the table regarding the important subject of providing safety from "needlestick accidents" to health care workers. The advantage of the Lasette is that it makes a hole for drawing blood from the finger using laser light and eliminates the possibility of a needlestick accident.

Dr. Lohrding further commented, "We are very excited about the contributions that members of our management team continue to make, ensuring the continued success of our Company. For example, Cell Robotics has appointed Steve Aiken as Vice President for R&D. Mr. Aiken made a major contribution toward making the current small Lasette durable enough to withstand the heavy use requirements of the clinical setting.

"The only modification required was a different disposable for the clinical application. The result is a professional device that is small and affordable for clinics and hospitals. Before joining Cell Robotics, Mr. Aiken was a chief engineer at Decade Optical Systems. He also worked as an engineer at Core Group, Logicon RDA, Titan Corp., and Rockwell International.

"He is a member of the American Society for Laser Medicine and Surgery, the Institute of Electronics and Electrical Engineers, and the International Society of Optical Engineering, along with being published numerous times, including in the DLTR Technical Digest. Mr. Aiken received his Bachelor's of Science and Physics from the University of New Mexico," said Lohrding.

On the subject of the Company's recent sales and marketing additions, Travis Lee, vice president for Sales and Marketing, commented, "We are quite pleased with the sales and marketing staff that we have been able to attract to sell the exciting Lasette product. With the hiring of Harry Musumeci, will we have completed the hiring of our regional sales staff.

"Mr. Musumeci joins the staff next Monday as Eastern Sales Manager. He was the Eastern Area Manager for diabetes and other medical products calling on Managed Care Companies, Retail Outlet and Government sales for LifeChart.com. Prior to that position, he was a Regional account manager for Roche Diagnostics."

Other Key Appointments

On October 16, Patrick Manning joined Cell Robotics as its Western Sales Manager. He comes to the Company from Chronimed/MEDgensis where he was the Southern California territory manager for physicians offices, long-term care and retail distribution for all diabetic products. Manning was previously the retail distribution manager for all diabetic products for Southern California with Roche Diagnostics.

Tom Culler, who is the Company's new Mid-West Sales Manager, comes to CRII from Corometrics Medical Systems where he was a Senior Sales Consultant selling capital medical equipment to hospitals, clinics, physicians and DME's. Prior to that he was a Sales Representative with Brinkmann Instruments Inc. where he sold medical laboratory equipment.

The Southeast Sales manager is Elizabeth Reeves. Reeves was previously the Sales Manager for Transmedica International Inc. with duties that included selling medical laser product to medical professionals, paternity testing clinics, forensic laboratories, correctional facilities, and U.S. military facilities. Prior to that position, she was the International Sales Administrator for the same company. That position included locating and interviewing potential international distributors, negotiation and preparation of distributor contracts, and attending international trade shows.

Advertising Campaign

With a strong supply line of Lasettes and the ability to serve both the home-use and clinical market with the same product with different disposables, the Company is launching its advertising campaign targeting the clinical market. Cell Robotics will be placing ads in the American Association of Diabetic Educators (AADE) Journal, Clinical Diabetes and Diabetes. You can see copies of the ads on the Company's Web site located at www.cellrobotics.com. Included are ads that explain the Lasette(R) technology and testimonial ads from satisfied customers. These ads have already run in national publications targeted to the diabetic community, including Diabetes Forecast, Diabetes Self Management and Diabetes Interview.

Diabetes, a chronic disease, is the most costly of all diseases in the US and is the sixth leading cause of death worldwide. In the US over 800,000 new cases are diagnosed each year, or over one per minute for every minute in the year. The International Diabetes Institute provides the following numbers of people with diabetes by region: 16.9 million in North America, 23.7 million in Europe, 51.2 million in Asia and 12.6 million in Latin America.

Detailed information about purchasing the Lasette and media quality photographs can be found at www.cellrobotics.com or by calling 800/846-0590. Interested distributors should submit a form at http://www.cellrobotics.com/DIS_Form.html.

As a cautionary note to investors, certain matters discussed in this news release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings.